tiprankstipranks
Advertisement
Advertisement
Revelation Biosciences presents additional data from Prime Clinical Study
PremiumThe FlyRevelation Biosciences presents additional data from Prime Clinical Study
3M ago
Revelation Biosciences Shareholders Approve Warrant Share Issuance
Premium
Company Announcements
Revelation Biosciences Shareholders Approve Warrant Share Issuance
3M ago
Revelation Biosciences price target lowered to $16 from $20 at Roth Capital
Premium
The Fly
Revelation Biosciences price target lowered to $16 from $20 at Roth Capital
4M ago
Revelation reaches agreement with FDA on Gemini approval pathway
PremiumThe FlyRevelation reaches agreement with FDA on Gemini approval pathway
5M ago
Revelation Biosciences initiates GMP manufacturing of GEMINI
Premium
The Fly
Revelation Biosciences initiates GMP manufacturing of GEMINI
5M ago
Revelation Biosciences Extends Stock Warrants Expiration
Premium
Company Announcements
Revelation Biosciences Extends Stock Warrants Expiration
6M ago
Revelation Biosciences announces cancellation of Special Meeting
PremiumThe FlyRevelation Biosciences announces cancellation of Special Meeting
8M ago
Revelation Biosciences Inc. Advances Kidney Disease Treatment with Gemini Study
Premium
Company Announcements
Revelation Biosciences Inc. Advances Kidney Disease Treatment with Gemini Study
8M ago
Revelation Biosciences Adjourns Special Stockholders Meeting
Premium
Company Announcements
Revelation Biosciences Adjourns Special Stockholders Meeting
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100